Back to all Programs

Register here

Related Materials

Past event

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2024

Viral Hepatitis and Liver Disease

Therapeutic Drug Monitoring of Antiretrovirals – Is There a Future? | David Burger

Viral Hepatitis and Liver Disease

The Evolution of Antiretroviral Tissue Pharmacokinetics | Angela DM Kashuba

Viral Hepatitis and Liver Disease

Evolution of Long-Acting ARVs | Charles Flexner

Viral Hepatitis and Liver Disease

Modelling Design and Validations for Complex LA Medicines | Simone Perazzolo

Viral Hepatitis and Liver Disease

Optimizing TB Therapy for All Children | Rada Savic

Viral Hepatitis and Liver Disease

Perinatal and Paediatric Considerations for LA Medicines | Adeniyi Olagunju

Viral Hepatitis and Liver Disease

Regulatory Considerations for Emerging Infections | Kimberly Struble

Viral Hepatitis and Liver Disease

Drug-Drug Interactions in Specific Populations | Catia Marzolini

Viral Hepatitis and Liver Disease

Case Presentation: Unmasking the Enemy: Enzalutamide-Induced HIV Treatment Failure | Pierre Giguère

Viral Hepatitis and Liver Disease

Gilead Sciences: HIV Drug Development Pipeline | Keith Dunn

Viral Hepatitis and Liver Disease

Controversies and Consistencies Whether Men and Women Respond Differently to PrEP | Melanie Nicol

Viral Hepatitis and Liver Disease

The History of Pharmacology at the University of Liverpool | David Back

Viral Hepatitis and Liver Disease

Long-Acting Antiretroviral Delivery Intravaginally - Regional PBPK Models | Robert R. Bies

Viral Hepatitis and Liver Disease

Micro-Array Patches | Lalitkumar Vora

Viral Hepatitis and Liver Disease

Models to Address Whether Men and Women Respond Differently to PrEP | Craig W. Hendrix